Itron [ITRI] vs Cognex [CGNX] Detailed Stock Comparison
Itron
NASDAQ
Loading...
Cognex
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Itron wins in 13 metrics, Cognex wins in 6 metrics, with 0 ties. Itron appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Itron | Cognex | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.31 | 57.01 | Itron |
| Price-to-Book Ratio | 3.53 | 4.58 | Itron |
| Debt-to-Equity Ratio | 77.85 | 5.52 | Cognex |
| PEG Ratio | 25.19 | 42.76 | Itron |
| EV/EBITDA | 16.74 | 40.84 | Itron |
| Profit Margin (TTM) | 11.05% | 13.13% | Cognex |
| Operating Margin (TTM) | 12.70% | 17.44% | Cognex |
| EBITDA Margin (TTM) | 12.70% | 17.44% | Cognex |
| Return on Equity | 18.76% | 8.10% | Itron |
| Return on Assets (TTM) | 5.26% | 4.11% | Itron |
| Free Cash Flow (TTM) | $207.61M | $134.04M | Itron |
| Dividend Yield | N/A | 0.96% | N/A |
| 1-Year Return | 27.46% | 5.65% | Itron |
| Price-to-Sales Ratio (TTM) | 2.34 | 7.41 | Itron |
| Enterprise Value | $5.77B | $6.72B | Cognex |
| EV/Revenue Ratio | 2.36 | 7.23 | Itron |
| Gross Profit Margin (TTM) | 36.85% | 67.39% | Cognex |
| Revenue per Share (TTM) | $54 | $5 | Itron |
| Earnings per Share (Diluted) | $5.85 | $0.72 | Itron |
| Beta (Stock Volatility) | 1.35 | 1.47 | Itron |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Itron vs Cognex Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Itron | 0.64% | 1.87% | -6.05% | 16.33% | 18.49% | 15.62% |
| Cognex | -1.09% | 1.09% | 23.48% | 39.06% | 3.67% | 14.59% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Itron | 27.46% | 127.73% | 89.49% | 273.67% | 120.06% | 141.59% |
| Cognex | 5.65% | -15.12% | -39.35% | 121.24% | 723.54% | 430.18% |
Performance & Financial Health Analysis: Itron vs Cognex
| Metric | ITRI | CGNX |
|---|---|---|
| Market Information | ||
| Market Cap | $5.73B | $6.89B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 989,660 | 2,607,209 |
| 90 Day Avg. Volume | 654,103 | 2,043,183 |
| Last Close | $125.48 | $40.91 |
| 52 Week Range | $90.11 - $140.04 | $22.67 - $44.17 |
| % from 52W High | -10.40% | -7.38% |
| All-Time High | $140.04 (Jul 30, 2025) | $101.82 (Feb 08, 2021) |
| % from All-Time High | -10.40% | -59.82% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.00% | 0.04% |
| Quarterly Earnings Growth | 0.33% | 0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.13% |
| Operating Margin (TTM) | 0.13% | 0.17% |
| Return on Equity (TTM) | 0.19% | 0.08% |
| Debt to Equity (MRQ) | 77.85 | 5.52 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $35.29 | $8.97 |
| Cash per Share (MRQ) | $26.78 | $1.36 |
| Operating Cash Flow (TTM) | $313.95M | $190.80M |
| Levered Free Cash Flow (TTM) | $246.81M | $166.53M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.96% |
| Last 12-Month Dividend | N/A | $0.39 |
Valuation & Enterprise Metrics Analysis: Itron vs Cognex
| Metric | ITRI | CGNX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.31 | 57.01 |
| Forward P/E | 25.19 | 42.76 |
| PEG Ratio | 25.19 | 42.76 |
| Price to Sales (TTM) | 2.34 | 7.41 |
| Price to Book (MRQ) | 3.53 | 4.58 |
| Market Capitalization | ||
| Market Capitalization | $5.73B | $6.89B |
| Enterprise Value | $5.77B | $6.72B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.36 | 7.23 |
| Enterprise to EBITDA | 16.74 | 40.84 |
| Risk & Other Metrics | ||
| Beta | 1.35 | 1.47 |
| Book Value per Share (MRQ) | $35.29 | $8.97 |
Financial Statements Comparison: Itron vs Cognex
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ITRI | CGNX |
|---|---|---|
| Revenue/Sales | $607.15M | $216.04M |
| Cost of Goods Sold | $389.93M | $71.71M |
| Gross Profit | $217.22M | $144.32M |
| Research & Development | $50.09M | $34.73M |
| Operating Income (EBIT) | $75.74M | $26.09M |
| EBITDA | $99.47M | $32.49M |
| Pre-Tax Income | $82.28M | $27.80M |
| Income Tax | $16.93M | $4.20M |
| Net Income (Profit) | $65.35M | $23.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ITRI | CGNX |
|---|---|---|
| Cash & Equivalents | $1.12B | $143.74M |
| Total Current Assets | $1.90B | $577.68M |
| Total Current Liabilities | $983.42M | $183.96M |
| Long-Term Debt | $808.46M | $63.43M |
| Total Shareholders Equity | $1.51B | $1.45B |
| Retained Earnings | $-123.83M | $405.95M |
| Property, Plant & Equipment | $27.23M | $166.19M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ITRI | CGNX |
|---|---|---|
| Operating Cash Flow | $120.73M | $47.37M |
| Capital Expenditures | $-4.64M | $-2.50M |
| Free Cash Flow | $67.48M | $38.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-102.23M |
Short Interest & Institutional Ownership Analysis
| Metric | ITRI | CGNX |
|---|---|---|
| Shares Short | 3.74M | 5.74M |
| Short Ratio | 7.01 | 3.35 |
| Short % of Float | 0.12% | 0.04% |
| Average Daily Volume (10 Day) | 989,660 | 2,607,209 |
| Average Daily Volume (90 Day) | 654,103 | 2,043,183 |
| Shares Outstanding | 45.13M | 170.43M |
| Float Shares | 45.10M | 160.31M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 1.14% | 0.99% |
Dividend Analysis & Yield Comparison: Itron vs Cognex
| Metric | ITRI | CGNX |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.39 |
| Last 12-Month Dividend Yield | N/A | 0.96% |
| 3-Year Avg Annual Dividend | N/A | $0.32 |
| 3-Year Avg Dividend Yield | N/A | 0.18% |
| 3-Year Total Dividends | N/A | $0.95 |
| Ex-Dividend Date | N/A | Aug 14, 2025 |